It is used in the treatment of diseases caused by streptococcus and staphylococcus.

Description

A transparent liquid of varying intensity yellow color with a specific taste.
 

Composition:

Active ingredient 

1 ml of the drug contains a mixture of sterile filtrates of bacteria: Streptococcus, Staphylococcus, E. coli, Pseudomonas aeruginosa, Proteus phagolysates with a titer of each phage not less than 1X105;
 

Pharmaceutical form 

Spray, 20 ml sterile solution for local and external use. 
 

Pharmacotherapeutic group

Specific antibacterial drug.
 

ATC code:  J01XX.
 

Pharmacological action:  A bacteriophage is a bacteria-specific virus that adsorbs to the cell membrane of a homologous bacterium, disrupts its integrity, penetrates the cell, multiplies, and causes its lysis. 

Fagio® Spray contains only virulent phages selected from bacteria ( Streptococcus, Staphylococcus, E.Coli, Pseudomonas aeruginosa, Proteus ), which ensures the guaranteed high activity and effectiveness of the drug. Regardless of the route of administration, bacteriophage preparations are quickly absorbed into the blood and lymph and easily reach the site of the disease. Excreted from the body: the main part is excreted through the kidneys, which sanitize the urinary tract, the rest - through the gastrointestinal tract.  
 

Therapeutic indications:  (during complex therapy)

Fagio® Spray is used for the prevention and treatment of purulent diseases caused by bacteria ( Streptococcus, Staphylococcus, E.Coli, Pseudomonas aeruginosa, Proteus ) in patients of all age groups and high-risk groups.  
 

The drug is used:

For the treatment of pharyngitis, laryngitis and tonsillitis.

In case of inflammation of the oral mucosa: treatment and prevention of glossitis, gingivitis, stomatitis.

For the treatment of purulent wounds, burns, abscesses, phlegmons, furuncles, carbuncles, panaritiums.

In purulent-inflammatory diseases of newborns (omphalitis, pyoderma)

In other diseases caused by bacteria: Streptococcus, Staphylococcus, E. coli, Pseudomonas aeruginosa, Proteus.

For the purpose of prophylaxis, the drug is used:

After various oral manipulations and surgeries (periodontal procedures, tooth extraction, etc.). 

For the treatment of fresh wounds, both in stationary and household conditions; 

For the prevention of purulent complications during surgical manipulations and operations;

For the prevention of purulent complications of acute respiratory viral infections;

Contraindications: Hypersensitivity to any component of the contents of the vial. 

Special warnings: 

No special precautions are provided when using the drug.

The vial with the drug should be shaken before use. The contents of the vial should be clear and free of sediment. 

It is not permissible to take the drug in a cloudy state!

After using the medicine, the vial with the remaining liquid in it is stored in the refrigerator. 

It is forbidden to freeze the drug! 

After opening (from the first spray), the drug is stored for 20 days at a temperature of 2°C - 8°C.

It is permissible to swallow the drug when treating the oral mucosa.

Interaction with other medicinal products:  Incompatibility of the drug with other medicinal products has not been established. It can be used in combination with other medicinal products in complex treatment, including antibacterial drugs (antibiotics).
 

Pregnancy and lactation:  The drug can be used during pregnancy and lactation.
 

Effects on ability to drive and use machines:

Taking the drug does not affect the ability to drive or use machines. 

Keep out of reach of children!
 

Administration and dosage:  One of the important prerequisites for the effectiveness of phage therapy is determining the sensitivity of the disease-causing microorganism to the phage. The drug is especially effective when used in the early stages of the disease and when applied directly to the focus of infection. 

Fagio spray must be prescribed by a doctor.

For oral (mouth and throat) use, the drug should be taken half an hour before or after meals to achieve a therapeutic effect.

Children under 6 years old - 5 sprays, at intervals of 2-4 hours, 4-5 times a day.

From 6 to 12 years old - 8 sprays at 2-4 hour intervals, 4-5 times a day.

Adults and the elderly - 8-10 sprays at intervals of 2-4 hours, 4-5 times a day.

Duration of treatment is 5-10 days.

For external use, the dosage of the drug (amount of spray) is determined by the doctor based on the size of the affected area.  

Note:  If chemical antiseptics were used to treat the wound and/or cavity, 3 hours should have passed since the treatment before applying the drug or the relevant areas should be treated with sterile 0.9% saline.
 

Overdose: 

Data on the consequences of overdose of bacteriophage preparations are not known.
 

Side effects:  The drug is non-toxic, and no data have been identified on side effects or harmful effects on the human body after its use.

Release form and packaging: 

The 20 ml glass bottle is filled with liquid and closed with a hermetic mechanical sprayer, which in turn is covered with a transparent lid. A cardboard box contains 1 20 ml glass bottle along with instructions for use.
 

Storage and transportation conditions: 

Store in a dry place protected from light at a temperature of 2°C - 25°C.

Transportation is possible by all types of closed transport that ensure a stable temperature regime is maintained throughout the transportation period. 
 

Expiration date: 

When stored properly, the product is valid for 2 years from the date of manufacture indicated on the packaging. 

It is not allowed to use the drug after the expiration date. 
 

Dispensing mode:  Pharmaceutical product group III, dispensed without a prescription.